← All peptides
Cognitive & Nootropic
Preclinical

FGL (FGL-S)

Also known as: FGL, FGL-S

FGL is a synthetic peptide derived from the neural cell adhesion molecule (NCAM) studied as a cognitive enhancer and neuroprotective agent.

Last updated

Mechanism of Action

FGL is a short peptide mimetic of the second fibronectin type III module of NCAM that binds and activates the fibroblast growth factor receptor 1 (FGFR1). FGFR1 activation triggers downstream signaling that promotes neurite outgrowth, synaptic plasticity, and long-term potentiation in the hippocampus. It also exerts anti-inflammatory and neuroprotective effects by modulating microglial activation and reducing neuronal apoptosis in injury and aging models.

Half-life
Short peptide half-life; rapidly cleared from plasma
Administration Routes
subcutaneous, intranasal
Research Status
Preclinical

Reported Benefits

  • Promotes synaptic plasticity and long-term potentiation
  • Studied for memory and learning enhancement
  • Neuroprotective in injury and neurodegeneration models
  • Anti-inflammatory effects on neural tissue
  • Investigated for cognitive recovery after stress or injury

Potential Side Effects

  • Limited human data; safety not well established
  • Possible injection-site reaction
  • Theoretical effects on cell proliferation via FGFR signaling
  • Unknown long-term effects

Common Dosing

Animal research has used parenteral microgram-to-milligram-per-kilogram doses; no validated human regimen exists. For research use only; not personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Known hypersensitivity to the peptide
  • Active or history of malignancy, given FGFR pathway activation
  • Pregnancy or breastfeeding
  • A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation

    2004

    View
  • An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons

    2004

    View
  • Facilitation of AMPA receptor synaptic delivery as a molecular mechanism for cognitive enhancement

    2012

    View
  • The neural cell adhesion molecule-derived peptide FGL facilitates long-term plasticity in the dentate gyrus in vivo

    2011

    View
  • A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo

    2005

    View

It mimics part of NCAM to activate fibroblast growth factor receptor 1 (FGFR1), driving neurite outgrowth and synaptic plasticity.

No. FGL is a preclinical research peptide studied mainly in cell and animal models of memory and neuroprotection.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.